Latest immunotherapy news
Stapokibart Found to Be Superior to Placebo for Severe Chronic Rhinosinusitis With Polyps
posted August 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma
posted August 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
posted August 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Patients With Leukemia Have Higher Infection Risk During Immunoglobulin Replacement Therapy
posted August 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Childhood Cancer Survivors Often Have Mental Distress in Adulthood 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML Related Articles
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment Monthly Specialist Briefings
Stay Connected
